panel-4-post-grant-proceedings-in-life-sciences
29 May 2026VideosRegulation & IndustryPhil Hirschhorn, Panitch Law | Erin Dunston, Panitch Schwarze | Mythili Markowski, Regeneron | Victoria Pedanou, Sanofi

WATCH: Post-grant proceedings in life sciences—strategic offense and defense in the US and Europe

Phil Hirschhorn, Partner at Panitch Law, moderates a discussion with Erin Dunston, Partner at Panitch Schwarze; Mythili Markowski, Patent Attorney at Regeneron; and Victoria Pedanou, Patent Counsel at Sanofi.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Regulation & Industry
5 November 2026   Things can go “sideways pretty quickly” if the two sides of pharma protection are not communicating with each other, said a senior panel of industry counsel at LSPN Fall.
Regulation & Industry
5 November 2026   From November 1, oral proceedings before a Board of Appeal can be audio-recorded and transcribed using artificial intelligence, but any material generated will be kept internal and will not form part of the file or be made available
Regulation & Industry
30 October 2026   With its goal of becoming a global life sciences leader still some way off, the UK is betting on new investment, AI and regulatory changes to help close the gap, according to the government’s autumn budget.